Indications, Complications and Outcome of Intravitreal Injections in Phakics and Pseudophakics

Chowdhury S, Srivastava M and Chowdhury N

Published on: 2019-08-12

Abstract

An intravitreal injection enables highly targeted drug therapy, maximizing therapeutic drug delivery. A prospective study of 100 consecutive cases of intravitreal injections was done in tertiary hospital to analyse indications, complication and outcome in phakic and pseudophakic patients. For the same Intravitreal Bevacizumab (1.25mg) or Ranibizumab (0.5mg) or Triamcinolone (4mg) was given under standard protocol. 100 eyes of 100 patients treated with intravitreal anti VEGF and steroid. Male predominance (60%), M: F ratio 3:2.50 pseudophakic & 50 phakic eyes. 60% Bevacizumab, 20% Ranibizumab and 20% Triamcinolone. The procedure of intravitreal injection is generally safe but some procedure related and some drug related adverse event occur but almost all of it is not serious.